Sphingosine 1-phosphate receptor modulator ONO-4641 stimulates CD11b + Gr-1 + cell expansion and inhibits lymphocyte infiltration in the lungs to ameliorate murine pulmonary emphysema
Sphingolipids play a pivotal role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, little is known about the precise roles of sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, and its receptor modulation in COPD. In this study, we demonstrated that the...
Saved in:
Published in: | Mucosal immunology 2018-11, Vol.11 (6), p.1606-1620 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | eng |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Sphingolipids play a pivotal role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, little is known about the precise roles of sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, and its receptor modulation in COPD. In this study, we demonstrated that the S1P receptor modulator ONO-4641 induced the expansion of lung CD11b
Gr-1
cells and lymphocytopenia in naive mice. ONO-4641-expanded CD11b
Gr-1
cells showed higher arginase-1 activity, decreased T cell proliferation, and lower IFN-γ production in CD3
T cells, similar to the features of myeloid-derived suppressor cells. ONO-4641 treatment decreased airspace enlargement in elastase-induced and cigarette smoke-induced emphysema models and attenuated emphysema exacerbation induced by post-elastase pneumococcal infection, which was also associated with an increased number of lung CD11b
Gr-1
cells. Adoptive transfer of ONO-4641-expanded CD11b
Gr-1
cells protected against elastase-induced emphysema. Lymphocytopenia observed in these models likely contributed to beneficial ONO-4641 effects. Thus, ONO-4641 attenuated murine pulmonary emphysema by expanding lung CD11b
Gr-1
cell populations and inducing lymphocytopenia. The S1P receptor might be a promising target for strategies aimed at ameliorating pulmonary emphysema progression. |
---|---|
ISSN: | 1933-0219 1935-3456 |